Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study.

Autor: Hu, Chunhong, Wu, Sixuan, Deng, Renfang, Wu, Yuanqiang, Pan, Yue, Shu, Long, Wu, Fang

Publikováno v: Cancer Medicine; Jan2023, Vol. 12 Issue 1, p266-273, 8p

[Research Progress of Immunotherapy for Non-small Cell Lung Cancer 
with Drive Gene Mutation].

Autor: Deng R; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.; Department of 
Oncology, Zhuzhou Second Hospital, Zhuzhou 412000, China., Zeng Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China., Pan Y; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China., Hu C; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.; Hunan Cancer Mega-data Intelligent Application and Engineering 
Research Centre, Changsha 410011, China., Wu F; Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.; Hunan Cancer Mega-data Intelligent Application and Engineering 
Research Centre, Changsha 410011, China.; Hunan Key Laboratory of Tumor Models and Individualized Medicine, Changsha 410011, China.; Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, Changsha 410011, China.

Publikováno v: Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 201-206.